Evidence map›Paper›PMID 42515403›Full record

ArticleSensors (Basel, Switzerland)2026

Toward Reliable Diabetic Retinopathy Screening.

Hendrio Bragança, Ítalo P Caliari, Wington L Vital, Antonio Fontenele, Sergio Cavalcante, Glaucio Messias

Abstract read
In one paragraph

Article in Sensors (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Hendrio BragançaNúcleo de Capacitação em Inteligência Artificial (NCIA), Fundação Paulo Feitoza-FPFtech, Av. Danilo de Matos Areosa, 1170, Distrito Industrial, Manaus 69075-351, Amazonas, Brazil.
Ítalo P CaliariNúcleo de Capacitação em Inteligência Artificial (NCIA), Fundação Paulo Feitoza-FPFtech, Av. Danilo de Matos Areosa, 1170, Distrito Industrial, Manaus 69075-351, Amazonas, Brazil.
Wington L VitalNúcleo de Capacitação em Inteligência Artificial (NCIA), Fundação Paulo Feitoza-FPFtech, Av. Danilo de Matos Areosa, 1170, Distrito Industrial, Manaus 69075-351, Amazonas, Brazil.ORCID 0000-0003-1634-4441
Antonio FonteneleNúcleo de Capacitação em Inteligência Artificial (NCIA), Fundação Paulo Feitoza-FPFtech, Av. Danilo de Matos Areosa, 1170, Distrito Industrial, Manaus 69075-351, Amazonas, Brazil.ORCID 0009-0009-5078-1902
Sergio CavalcanteNúcleo de Capacitação em Inteligência Artificial (NCIA), Fundação Paulo Feitoza-FPFtech, Av. Danilo de Matos Areosa, 1170, Distrito Industrial, Manaus 69075-351, Amazonas, Brazil.
Glaucio MessiasNúcleo de Capacitação em Inteligência Artificial (NCIA), Fundação Paulo Feitoza-FPFtech, Av. Danilo de Matos Areosa, 1170, Distrito Industrial, Manaus 69075-351, Amazonas, Brazil.

Funding

Fundação Desembargador Paulo Feitosa (FPFtech) N/A
6 · The paper itself

Abstract

Diabetic retinopathy (DR) grading requires reliable five-grade severity assessment under substantial acquisition variability and cross-dataset distribution shift. We propose PRISM-DR, a multi-objective five-grade DR grading framework trained under a gradient-partitioned strategy. The architecture is organized as a feedforward pipeline: a data-driven preprocessing stage followed by a ConvNeXtV2-Base backbone, a Recurrent BiFPN neck for multi-scale feature fusion, a Frequency-Aware Fusion module, a lightweight multi-scale reasoning transformer, dual classification heads with gradient-isolated pathways (categorical and ordinal), and a prototype memory module for embedding regularization. The CORAL ordinal head operates through a dedicated projection layer and is gradient-isolated from the backbone; the backbone is shaped by the cross-entropy, prototype contrastive, and view-consistency objectives, which carry indirect ordinal signal through severity-weighted class penalties and grade-indexed cluster regularization. The model is trained in a multi-crop setting with a phased loss curriculum designed for severely imbalanced DR datasets. Evaluated across six datasets under Fixed-Source, Multi-Target (FSMT) protocols, PRISM-DR trained on EyePACS + DDR achieves QWK of 0.835 on IDRiD, 0.865 on APTOS2019, and 0.720 on Messidor-2, with in-domain QWK = 0.920 and AUC-PR = 0.941 on EyePACS, outperforming RETFound, RETFound-Green, and MedGemma-4B in AUC-PR across all evaluated datasets. Quantitative interpretability evaluation against 755 expert-annotated lesion images yields 8.0× Energy Ratio Enrichment and a FAF gate retention ratio of 4.4× inside lesion regions, confirming that anatomically plausible spatial priors emerge from grade-level supervision alone, without pixel-level annotation. PRISM-DR establishes a superior accuracy-robustness-capacity trade-off for scalable, automated DR screening.

Indexed as

Diabetic RetinopathyAlgorithmsHumansdiabetic retinopathy gradingexplainable artificial intelligencefrequency-aware fusionmulti-scale feature fusionordinal learning

Identifiers

PMID42515403
PMCPMC13418815

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.